-
1
-
-
2542509446
-
Mortality and causes of death in schizophrenia in Stockholm county, Sweden
-
Osby U., Correia N., and Brandt L. Mortality and causes of death in schizophrenia in Stockholm county, Sweden Schiz Res 45 2000 21 28
-
(2000)
Schiz Res
, vol.45
, pp. 21-28
-
-
Osby, U.1
Correia, N.2
Brandt, L.3
-
2
-
-
2342641227
-
Cardiovascular illness and hyperlipidemia in patients with schizophrenia
-
Meyer J.M. Nasrallah H. American Psychiatric Press, Inc Washington, DC
-
Meyer J.M. Cardiovascular illness and hyperlipidemia in patients with schizophrenia Meyer J.M. Nasrallah H. Medical Illness and Schizophrenia 2003 American Psychiatric Press, Inc Washington, DC 59 89
-
(2003)
Medical Illness and Schizophrenia
, pp. 59-89
-
-
Meyer, J.M.1
-
4
-
-
0034837376
-
Cardiovascular morbidity and mortality associated with the metabolic syndrome
-
Isomaa B., Almgren P., and Tuomi T. Cardiovascular morbidity and mortality associated with the metabolic syndrome Diabetes Care 24 2001 683 689
-
(2001)
Diabetes Care
, vol.24
, pp. 683-689
-
-
Isomaa, B.1
Almgren, P.2
Tuomi, T.3
-
5
-
-
0035897696
-
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
-
Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) JAMA 285 2001 2486 2497
-
(2001)
JAMA
, vol.285
, pp. 2486-2497
-
-
-
6
-
-
0842277242
-
Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientificissues related to definition
-
Grundy S.M., Brewer B., and Cleeman J.I. American Heart Association and the National Heart, Lung, and Blood Institute Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientificissues related to definition Circulation 109 2004 433 438
-
(2004)
Circulation
, vol.109
, pp. 433-438
-
-
Grundy, S.M.1
Brewer, B.2
Heart Association, C.3
National Heart, T.4
Lung5
Blood Institute, J.I.6
-
7
-
-
0037116641
-
Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey
-
Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the metabolic syndrome among US adults: Findings from the third National Health and Nutrition Examination Survey JAMA 287 2002 356 359
-
(2002)
JAMA
, vol.287
, pp. 356-359
-
-
Ford, E.S.1
Giles, W.H.2
Dietz, W.H.3
-
8
-
-
4644279733
-
Increasing prevalence of the metabolic syndrome among US adults
-
Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among US adults Diabetes Care 27 2004 2444 2449
-
(2004)
Diabetes Care
, vol.27
, pp. 2444-2449
-
-
Ford, E.S.1
Giles, W.H.2
Mokdad, A.H.3
-
9
-
-
0037463608
-
The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994
-
Park Y.W., Zhu S., and Palaniappan L. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 2003 427 436
-
(2003)
Arch Intern Med
, vol.163
, pp. 427-436
-
-
Park, Y.W.1
Zhu, S.2
Palaniappan, L.3
-
10
-
-
1842844950
-
Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes
-
American Diabetes Association, American Psychiatric Association, American Association of Clinical Endocrinologists, and North American Association for the Study of Obesity Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes J Clin Psychiatry 65 2004 267 272
-
(2004)
J Clin Psychiatry
, vol.65
, pp. 267-272
-
-
-
11
-
-
0033756432
-
Prevalence and correlates of diabetes in national schizophrenia samples
-
Dixon L., Weiden P., and Delahanty J. Prevalence and correlates of diabetes in national schizophrenia samples Schizophren Bull 26 2000 903 912
-
(2000)
Schizophren Bull
, vol.26
, pp. 903-912
-
-
Dixon, L.1
Weiden, P.2
Delahanty, J.3
-
12
-
-
1842684117
-
Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia
-
Bushe C., and Holt R. Prevalence of diabetes and impaired glucose tolerance in patients with schizophrenia Br J Psychiatry Suppl 47 2004 S67 S71
-
(2004)
Br J Psychiatry Suppl
, vol.47
-
-
Bushe, C.1
Holt, R.2
-
13
-
-
27744502054
-
Prevalence of the metabolic syndrome in patients with schizophre nia: Baseline results from the Clinical Antipsychotic Trials of InterventionEffectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III
-
McEvoy J.P., Meyer J.M., and Goff D.C. Prevalence of the metabolic syndrome in patients with schizophre nia: Baseline results from the Clinical Antipsychotic Trials of InterventionEffectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III Schizophr Res 80 2005 19 32
-
(2005)
Schizophr Res
, vol.80
, pp. 19-32
-
-
McEvoy, J.P.1
Meyer, J.M.2
Goff, D.C.3
-
14
-
-
0038448311
-
The National Institute of Mental Health Clinical Antipsy chotic Trials of Intervention Effectiveness (CATIE) project: Schizophrenia trial design and protocol development
-
Stroup T.S., McEvoy J.P., and Swartz M.S. The National Institute of Mental Health Clinical Antipsy chotic Trials of Intervention Effectiveness (CATIE) project: Schizophrenia trial design and protocol development Schizophr Bull 29 2003 15 31
-
(2003)
Schizophr Bull
, vol.29
, pp. 15-31
-
-
Stroup, T.S.1
McEvoy, J.P.2
Swartz, M.S.3
-
16
-
-
4043123270
-
The prevalence of the metabolic syndrome in patients with schizo affective disorder-bipolar subtype
-
Basu R., Brar J.S., and Chengappa K.N. The prevalence of the metabolic syndrome in patients with schizo affective disorder-bipolar subtype Bipolar Disord 6 2004 314 318
-
(2004)
Bipolar Disord
, vol.6
, pp. 314-318
-
-
Basu, R.1
Brar, J.S.2
Chengappa, K.N.3
-
17
-
-
11844270509
-
Characterizing coronary heart disease risk in chronic schizophre nia: High prevalence of the metabolic syndrome
-
Cohn T., Prud'homme D., and Streiner D. Characterizing coronary heart disease risk in chronic schizophre nia: High prevalence of the metabolic syndrome Can J Psychiatry 49 2004 753 760
-
(2004)
Can J Psychiatry
, vol.49
, pp. 753-760
-
-
Cohn, T.1
Prud'Homme, D.2
Streiner, D.3
-
21
-
-
33644509605
-
Prevalence of the metabolicsyndrome in veterans with schizophrenia
-
In press.
-
Meyer JM, Loh C, Leckband SG. Prevalence of the metabolicsyndrome in veterans with schizophrenia. J Psych Pract. In press.
-
J Psych Pract
-
-
Meyer, J.M.1
Loh, C.2
Leckband, S.G.3
-
22
-
-
0035684803
-
Effects of atypical antipsychotics on weight and serum lipid levels
-
Meyer J.M. Effects of atypical antipsychotics on weight and serum lipid levels J Clin Psychiatry 62 Suppl 27 2001 27 34
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.27 SUPPL.
, pp. 27-34
-
-
Meyer, J.M.1
-
23
-
-
0036001466
-
Phenomenology of and risk factors for newonset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases
-
Jin H., Meyer J.M., and Jeste D.V. Phenomenology of and risk factors for newonset diabetes mellitus and diabetic ketoacidosis associated with atypical antipsychotics: An analysis of 45 published cases Ann Clin Psychiatry 14 2002 59 64
-
(2002)
Ann Clin Psychiatry
, vol.14
, pp. 59-64
-
-
Jin, H.1
Meyer, J.M.2
Jeste, D.V.3
-
24
-
-
3342901698
-
Physical health monitoring of patients with schizophrenia
-
Marder S.R., Essock S.M., and Miller A.L. Physical health monitoring of patients with schizophrenia Am J Psychiatry 161 2004 1334 1349
-
(2004)
Am J Psychiatry
, vol.161
, pp. 1334-1349
-
-
Marder, S.R.1
Essock, S.M.2
Miller, A.L.3
-
25
-
-
0345107248
-
Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone
-
Weiden P.J., Daniel D.G., Simpson G.M., and Romano S.J. Improvement in indices of health status in outpatients with schizophrenia switched to ziprasidone J Clin Psychopharmacol 23 2003 595 600
-
(2003)
J Clin Psychopharmacol
, vol.23
, pp. 595-600
-
-
Weiden, P.J.1
Daniel, D.G.2
Simpson, G.M.3
Romano, S.J.4
-
27
-
-
14644439810
-
Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder
-
Brar J.S., Ganguli R., and Pandina G. Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder J Clin Psychiatry 66 2005 205 212
-
(2005)
J Clin Psychiatry
, vol.66
, pp. 205-212
-
-
Brar, J.S.1
Ganguli, R.2
Pandina, G.3
-
29
-
-
0023606101
-
The positive and negative syndrome scale (PANSS) for schizophrenia
-
Kay S.R., Fiszbein A., and Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
-
(1987)
Schizophr Bull
, vol.13
, pp. 261-276
-
-
Kay, S.R.1
Fiszbein, A.2
Opler, L.A.3
-
30
-
-
0037317444
-
Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia
-
Ryan M.C., Collins P., and Thakore J.H. Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia Am J Psychiatry 160 2003 284 289
-
(2003)
Am J Psychiatry
, vol.160
, pp. 284-289
-
-
Ryan, M.C.1
Collins, P.2
Thakore, J.H.3
-
31
-
-
1142285313
-
The effects of atypical antipsychotics on visceral fat distribu tion in first episode, drug-naive patients with schizophrenia
-
[published correction appears in Life Sci. 2004; 75:2851] Ryan M.C., Flanagan S., and Kinsella U. The effects of atypical antipsychotics on visceral fat distribu tion in first episode, drug-naive patients with schizophrenia Life Sci 74 2004 1999 2008
-
(2004)
Life Sci
, vol.74
, pp. 1999-2008
-
-
Ryan, M.C.1
Flanagan, S.2
Kinsella, U.3
-
32
-
-
0346373688
-
Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia
-
Zhang Z.J., Yao Z.J., and Liu W. Effects of antipsychotics on fat deposition and changes in leptin and insulin levels. Magnetic resonance imaging study of previously untreated people with schizophrenia Br J Psychiatry 184 2004 58 62
-
(2004)
Br J Psychiatry
, vol.184
, pp. 58-62
-
-
Zhang, Z.J.1
Yao, Z.J.2
Liu, W.3
-
33
-
-
1842666845
-
The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study
-
Ford E.S. The metabolic syndrome and mortality from cardiovascular disease and all-causes: Findings from the National Health and Nutrition Examination Survey II Mortality Study Atherosclerosis 173 2004 309 314
-
(2004)
Atherosclerosis
, vol.173
, pp. 309-314
-
-
Ford, E.S.1
-
34
-
-
85060840150
-
Acomprehensive review of behavioral interventions for weight management in schizophrenia
-
In press.
-
Loh C, Meyer JM, Leckband SG. Acomprehensive review of behavioral interventions for weight management in schizophrenia. Ann Clin Psychiatry. In press.
-
Ann Clin Psychiatry
-
-
Loh, C.1
Meyer, J.M.2
Leckband, S.G.3
-
35
-
-
4544276308
-
Guidelines for prevention and treatment of adverse effects of anti psychotic drugs on glucose-insulin homeostasis and lipid metabolism
-
Melkersson K.I., Dahl M.L., and Hulting A.L. Guidelines for prevention and treatment of adverse effects of anti psychotic drugs on glucose-insulin homeostasis and lipid metabolism Psychopharmacology (Berl) 175 2004 1 6
-
(2004)
Psychopharmacology (Berl)
, vol.175
, pp. 1-6
-
-
Melkersson, K.I.1
Dahl, M.L.2
Hulting, A.L.3
|